XML 26 R13.htm IDEA: XBRL DOCUMENT v3.23.2
Income Taxes
12 Months Ended
Mar. 31, 2023
Income Tax Disclosure [Abstract]  
Income Taxes

7. Income Taxes

Income tax expense consists of the following for the years ended March 31:

 

 

 

(In thousands)

 

 

 

2023

 

 

2022

 

Current:

 

 

 

 

 

 

Federal

 

$

22

 

 

$

116

 

State

 

 

10

 

 

 

35

 

Total current

 

 

32

 

 

 

151

 

Deferred:

 

 

 

 

 

 

Federal

 

 

708

 

 

 

800

 

State

 

 

677

 

 

 

97

 

Total deferred

 

 

1,385

 

 

 

897

 

Income tax expense

 

$

1,417

 

 

$

1,048

 

 

The net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes are reflected in deferred income taxes. Significant components of the Company’s deferred tax assets consist of the following as of March 31:

 

 

 

(In thousands)

 

Deferred Tax Assets

 

2023

 

 

2022

 

Allowance for credit losses not currently deductible
   for tax purposes

 

$

4,538

 

 

$

900

 

Share-based compensation

 

 

20

 

 

 

79

 

Federal and state net operating loss carryforwards

 

 

4,812

 

 

 

507

 

Right of use liability

 

 

43

 

 

 

1,094

 

Other items

 

 

87

 

 

 

175

 

Valuation Allowance

 

 

(9,457

)

 

 

-

 

Total deferred tax assets

 

 

43

 

 

 

2,755

 

 

 

 

 

 

 

 

Deferred tax liabilities

 

 

 

 

 

 

Right of use asset

 

 

43

 

 

 

1,062

 

Other items

 

 

-

 

 

 

308

 

Total deferred tax liabilities

 

 

43

 

 

 

1,370

 

Deferred income taxes

 

$

-

 

 

$

1,385

 

 

Income tax expense reflects an effective U.S. tax rate, which differs from the corporate tax rate for the following reasons:

 

 

 

(In thousands)

 

 

 

2023

 

 

2022

 

Income tax (benefit) expense at Federal statutory rate

 

$

(6,838

)

 

$

855

 

Increase (decrease) resulting from:

 

 

 

 

 

 

Change in Valuation Allowance

 

 

9,457

 

 

 

-

 

State income taxes, net of Federal benefit

 

 

(1,207

)

 

 

142

 

Other

 

 

5

 

 

 

51

 

Income tax expense

 

$

1,417

 

 

$

1,048

 

 

Management assesses the available positive and negative evidence to estimate whether sufficient future taxable income will be generated to permit use of the existing deferred tax assets. A significant piece of negative evidence evaluated was the cumulative pre-tax loss over the three-year period ended March 31, 2023. As of March 31, 2023, a full valuation allowance was recorded against the Company’s net deferred tax asset. The federal net operating loss ("NOL") generated for the year ended March 31, 2023 will carryforward indefinitely. Generally, state NOLs begin to expire March 31, 2039.

The Company considers the earnings of the Company’s U.S. subsidiaries to be indefinitely invested outside Canada on the basis of estimates that future domestic cash generation will be sufficient to meet future domestic cash needs and the Company’s specific plans for reinvestment of those subsidiary earnings. The Company has not recorded a deferred tax liability related to the Canadian income taxes and U.S. withholding taxes on approximately $121.0 million of undistributed earnings of the U.S. subsidiaries indefinitely invested outside Canada. If the Company decided to repatriate the U.S. earnings, it would need to adjust its income tax provision in the period the Company determined that the earnings will no longer be indefinitely invested outside of Canada.